Clinical trials
Phase 3 Cholestasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mirum Pharmaceuticals, Inc. | 3 |
| Albireo | 1 |
| Albireo, an Ipsen Company | 1 |
| GlaxoSmithKline | 1 |
| Kapiolani Medical Center For Women & Children | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| University of Michigan | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholestasis | 10 |
| Liver Diseases | 4 |
| Bile Duct Diseases | 2 |
| Biliary Tract Diseases | 2 |
| Digestive System Diseases | 2 |
| Adrenoleukodystrophy | 1 |
| Fibrosis | 1 |
| Hepatitis | 1 |
| Hyperphagia | 1 |
| Liver Cirrhosis, Biliary | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.